Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei Interaction between ciprofloxacin and chloroqune

Parasitology Research

Volumn 110, Issue 2, 2012, Pages 895-899

  Gbotosho, Grace Olusola ^a   Happi, Christian T ^a   Woranola, Olutayo ^a   Abiodun, Oyindamola O ^a,b   Sowunmi, Akin ^a   Oduola, Ayoade M ^c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CIPROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; DRUG RESPONSE; GENETIC STRAIN; INOCULATION; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; MALARIA; MALE; MICE; PARASITEMIA; PLASMODIUM BERGHEI; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; PLASMODIUM BERGHEI;

EID: 84857044374     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2573-3     Document Type: Article

References (25)

1. Andrade AA, de Pilla Varotti F, de Freitas IO, de Souza MV, Vasconcelos TR, Boechat N, Krettli AU (2007) Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin. Eur J Pharmacol 558(1-3):194-198 (Pubitemid 46331840)
2. Dahl EL, Rosenthal PJ (2007) Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother 51:3485-3490 (Pubitemid 47519333)
3. Divo AA, Sartorelli AC, Patton CL, Bia FJ (1988) Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 32:1182-1186
4. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361:455-467
5. Hamzah J, Skinner-Adams T, Davis TM (2000) In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone. Acta Trop 74:39-42
6. Hooper DC, Wolfson JS (1985) The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 28:716-721 (Pubitemid 16215549)
7. Hooper DC, Wolfson JS (1989) Mode of action of the quinolone antimicrobial agents: Review of recent information. Rev Infect Dis 11:S902-911
8. Ilo EC, Ilondu NA, Okwoli N, Brown SA, Elo-Ilo JC, Agbasi PU, Orisakwe OE (2006) Effect of chloroquine on the bioavailability of ciprofloxacin in human. Am J Ther 13:432-435 (Pubitemid 44435016)
9. Ilo CE, Ezejiofor NA, Agbakoba N, Brown SA, Maduagwuna CA, Agbasi PU, Orisakwe OE (2008) Effect of chloroquine on the urinary excretion of ciprofloxacin. Am J Ther 15:419-422
10. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366:1960-1963 (Pubitemid 41713986)
11. Kazzim OJ, Adegbolagun OM, Osho O, Anumudu CI (2006) Additive effects of ciprofloxacin on the in-vitro activity of chloroquine against a clinical isolate of Plasmodium falciparum. Ann Trop Med Parasitol 100:579-584 (Pubitemid 46940779)
12. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV (2006) Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:1959-1966 (Pubitemid 44708015)
13. Mahmoudi N, Ciceron L, Franetich JF, Farhati K, Silvie O, Eling W, Sauerwein R, Danis M, Mazier D, Derouin F (2003) In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother 47:2636-2639 (Pubitemid 36919470)
14. Maxwell A (1992) The molecular basis of quinolone action. Antimicrob Agents Chemother 30:409-416
15. McClean KL, Hitchman D, Shafran SD (1992) Norfloxacin is inferior to chloroquine for falciparum malaria in northwestern Zambia: A comparative clinical trial. J Inf Dis 165:904-907
16. Peters W (1965) Drug resistance in Plasmodium berghei I. Chloroquine resistance. Exp Parasitol 17:80-89
17. Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, Parzy D (2001) In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother 45:1746-1750 (Pubitemid 32466344)
18. Salmon D, Deloron P, Gaudin C, Malhotra K, Lebras J, Pocidalo JJ (1990) Activities of perfloxacin and ciprofloxacin against experimental malaria in mice. Antimicrob Agents Chemother 34:2327-2330
19. Stromberg A, Bjorkman A (1992) Ciprofloxacin does not achieve radical cure of Plasmodium falciparum infection in Sierra Leone. Trans R Soc Trop Med Hyg 86:373
20. Tripathi KD, Sharma AK, Valecha N, Biswas S (1993) In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Indian J Malariol 30:67-73 (Pubitemid 23256898)
21. Waller RF, McFadden GI (2005) The apicoplast: A review of the derived plastid of apicomplexan parasites. Cur Issues Mol Biol 7:57-79
22. WHO (2006) World Health Organization 2006 http://www.who.int/tropics/ malaria/en/Accessed 12th January 2011
23. WHO (2010) World Health Organization 2010 guidelines for treatment of malaria http://www.who.int/malaria/publications/atoz/9789241547925/en/Accessed 12th January 2011
24. Wilson RJ (2005) Parasite plastids: Approaching the endgame. Biol Rev Camb Philos Soc 80:129-153 (Pubitemid 40204268)
25. Yeo AE, Rieckmann KH (1994) Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases antimalarial activity. J Parasitol 80:158-160 (Pubitemid 24058902)